Clinical Trials Browser

OTHER × Advanced Malignant Solid Tumours × Clear all

NCT06888830 2025-06-19

A Phase I/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Initial Efficacy of JS212 in Subjects With Advanced Malignant Solid Tumour

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Malignant Solid Tumours